Drug wholesaler Cardinal Health
Inc. said it would sell its procedure kits manufacturing facility in
Waukegan, Ill. and its sterilization processes operations in El Paso,
Texas as part of a restructuring of its medical business.
Cardinal Health will move surgical kit production work from Illinois to plants in Juarez, Mexico and Fort Mill, South Carolina. The restructuring will also include a reorganization of the company's sales operation and marketing teams.
The company said it would cut
180 positions as part of the restructuring and take a related charge of
about $79 million. The company declined to comment on any impact the
restructuring might have on 2013.
The company is scheduled to report second-quarter earnings on Feb.5.
"As we analyzed that (medical segment) business, we felt that it would be best to shift the (sterilization) services to a third party who would retain our team and its assets, and provide us with contract sterilization services," Cardinal Health spokeswoman Debbie Mitchell told Reuters.
Sales at its medical business, which includes products such as surgical gowns, vials, plastic gloves and instruments, grew 1 percent to $2.4 billion in the quarter ended Sept. 30.
Cardinal blamed the slow growth on a slowdown in medical procedures.
Shares of the company, which have gained 11 percent in the last three months, closed at $44.68 on the New York Stock Exchange on Wednesday.
Cardinal Health will move surgical kit production work from Illinois to plants in Juarez, Mexico and Fort Mill, South Carolina. The restructuring will also include a reorganization of the company's sales operation and marketing teams.
The company is scheduled to report second-quarter earnings on Feb.5.
"As we analyzed that (medical segment) business, we felt that it would be best to shift the (sterilization) services to a third party who would retain our team and its assets, and provide us with contract sterilization services," Cardinal Health spokeswoman Debbie Mitchell told Reuters.
Sales at its medical business, which includes products such as surgical gowns, vials, plastic gloves and instruments, grew 1 percent to $2.4 billion in the quarter ended Sept. 30.
Cardinal blamed the slow growth on a slowdown in medical procedures.
Shares of the company, which have gained 11 percent in the last three months, closed at $44.68 on the New York Stock Exchange on Wednesday.
No comments:
Post a Comment